affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →
BPC-157 vs Cagrilintide
Two compounds, mechanism by mechanism. Where they overlap, where they don't, and which vendors stock each.
Mechanism
BPC-157
Synthetic peptide derived from a protein fragment in gastric juice. Mechanism not fully characterized; research suggests angiogenic and anti-inflammatory effects.
Full guide →Cagrilintide
Synthetic long-acting amylin analog. Activates amylin and calcitonin receptors. Studied in combination with semaglutide as CagriSema in Phase 3 obesity trials.
Full guide →Key facts
Use-case overlap
- tendon recovery
- gut healing
- soft tissue injury
none
- weight management research
- amylin-analog studies
- GLP-1 combination protocols
Where to buy
Sources
- [01]Pentadecapeptide BPC 157 and the central nervous system· BPC-157
- [02]Cagrilintide and semaglutide combination — The Lancet· Cagrilintide
- [03]Novo Nordisk CagriSema Phase 3 program· Cagrilintide
Other peptide matchups
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.